CAS 81586-39-2
:delta9-tetrahydrocannabinol-D3--*dea schedule I I
Description:
Delta-9-tetrahydrocannabinol-D3 (Δ9-THC-D3) is a synthetic analog of delta-9-tetrahydrocannabinol (Δ9-THC), the primary psychoactive component of cannabis. It is characterized by the incorporation of deuterium, a stable isotope of hydrogen, which enhances its stability and allows for specific applications in research, particularly in pharmacokinetics and metabolic studies. As a Schedule I controlled substance in the United States, Δ9-THC-D3 is subject to strict regulations, indicating that it is considered to have a high potential for abuse and no accepted medical use at the federal level. The compound exhibits similar pharmacological properties to Δ9-THC, including psychoactive effects, interaction with cannabinoid receptors in the brain, and potential therapeutic effects such as pain relief and appetite stimulation. Its chemical structure includes a bicyclic structure with a pentyl side chain, contributing to its lipophilicity and ability to cross biological membranes. Overall, Δ9-THC-D3 serves as a valuable tool in scientific research, particularly in understanding the effects and mechanisms of cannabinoids.
Formula:HC21H27O2
Synonyms:- D9-tetrahydrocannabinol-D3 100 ug per*ml in metha
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
(-)-trans-δ-9-THC-D3 (Dronabinol), 10mg/ml in Ethanol
CAS:Controlled ProductColor and Shape:Single Solution(-)-trans-δ-9-THC-D3 (Dronabinol), 0.1mg/ml in Ethanol
CAS:Controlled ProductColor and Shape:Single Solutionδ.9-THC-d3 CRM
CAS:Controlled Productdelta.9-THC-d3 CRM is a synthetic cannabinoid that is used as an analytical reference in the study of cannabis use. delta.9-THC-d3 CRM is trifluoroacetic acid derivative of delta.9-tetrahydrocannabinol (THC) with a deuterium atom at the 9 position, which makes it more stable and resistant to chemical degradation. The stability and relative ease of detection make this compound useful for pharmacokinetic studies and clinical trials on cannabis use. Delta.9-THC-d3 CRM has a terminal half life in urine samples of approximately 8 hours, but can be detected in urine up to 10 days after last use by LC/MS/MS method.Formula:C21H30O2Purity:Min. 95%Molecular weight:317.5 g/mol
